KEYNOTE-061: Response to subsequent therapy following second-line pembrolizumab or paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma

Author
Mandala, M.
Yoon, H.
Fuchs, C.
ÖZGÜROĞLU, Mustafa
Bang, Y.
Di Bartolomeo, M.
Ryu, M.
Fornaro, L.
Olesinski, T.
Caglevic, C.
Chung, H.
Muro, K.
Van Cutsem, E.
Elme, A.
Thuss-Patience, P.
Chau, I.
Ohtsu, A.
Wang, A.
Bhagia, P.
Lin, J.
Shih, C.
Shitara, K.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/4291
https://doi.org/10.1016/j.annonc.2020.04.065
Collections